| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SRY-box transcription factor 10 | 0.461 | 0.808 | 0.99 |
|
disease | 0.020 | None | 0.500 | 1 | 0 | 2007 | 2016 | ||||||||
|
semaphorin 3A | 0.500 | 0.808 | 0.98 |
|
disease | 0.030 | None | 0.667 | 1 | 0 | 2003 | 2015 | ||||||||
|
myosin heavy chain 2 | 0.619 | 0.731 | 3.7E-23 |
|
disease | 0.030 | None | 0.667 | 1 | 0 | 2008 | 2017 | ||||||||
|
nerve growth factor receptor | 0.477 | 0.846 | 9.8E-02 |
|
disease | 0.050 | None | 0.800 | 1 | 0 | 1999 | 2016 | ||||||||
|
C-X-C motif chemokine ligand 10 | 0.378 | 0.885 | 0.37 |
|
disease | 0.050 | None | 0.800 | 1 | 0 | 2003 | 2018 | ||||||||
|
aquaporin 4 | 0.456 | 0.885 | 2.3E-03 |
|
disease | 0.100 | None | 0.818 | 1 | 0 | 2007 | 2019 | ||||||||
|
platelet derived growth factor subunit B | 0.488 | 0.846 | 0.77 |
|
disease | 0.060 | None | 0.833 | 2 | 0 | 1989 | 2018 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.250 | None | 0.833 | 1 | 0 | 2000 | 2019 | ||||||||
|
Wnt family member 5A | 0.443 | 0.808 | 0.99 |
|
disease | 0.060 | None | 0.833 | 1 | 0 | 2007 | 2019 | ||||||||
|
heparanase | 0.425 | 0.808 | 2.3E-14 |
|
disease | 0.070 | None | 0.857 | 1 | 0 | 2003 | 2019 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.080 | None | 0.875 | 2 | 0 | 1998 | 2004 | ||||||||
|
nestin | 0.450 | 0.808 | 1.6E-06 |
|
disease | 0.100 | None | 0.875 | 1 | 0 | 2000 | 2020 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.400 | None | 0.893 | 1 | 0 | 2007 | 2019 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
disease | 0.100 | None | 0.900 | 1 | 0 | 1995 | 2017 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.100 | None | 0.909 | 4 | 0 | 1995 | 2014 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 0.909 | 3 | 0 | 1991 | 2019 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.100 | None | 0.909 | 1 | 0 | 2004 | 2019 | ||||||||
|
EPH receptor B2 | 0.374 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0.917 | 1 | 0 | 2002 | 2017 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.920 | 3 | 0 | 2001 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.100 | None | 0.923 | 1 | 0 | 2005 | 2015 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.100 | None | 0.923 | 1 | 0 | 1992 | 2017 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
disease | 0.100 | None | 0.929 | 4 | 0 | 2006 | 2019 | ||||||||
|
chitinase 3 like 1 | 0.419 | 0.885 | 1.1E-05 |
|
disease | 0.400 | None | 0.933 | 3 | 0 | 2002 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.936 | 5 | 0 | 1994 | 2020 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.600 | strong | 0.938 | 1 | 0 | 2001 | 2019 |